Which medications are effective in the management of acute exacerbations of bronchial asthma?

Which medications are effective in the management of acute exacerbations of bronchial asthma?

• A. Beta-2 adrenergic receptor agonists
• B. Anticholinergic drugs
• C. IV corticosteroids
• D. All of the above

Answer: (D)

During an acute asthma attack the goal is rapid relief of bronchospasm while also damping the inflammatory process that drives ongoing symptoms. Beta-2 adrenergic receptor agonists provide quick bronchodilation by stimulating smooth muscle relaxation in the airways, which immediately improves airflow, reduces wheeze, and eases shortness of breath. Anticholinergic drugs add to bronchodilation by blocking acetylcholine’s effect on airway smooth muscle, especially helpful when the attack is moderate to severe or not fully controlled by beta-agonists alone. They help reduce bronchomotor tone and mucus production, providing an extra boost in the acute setting. Systemic corticosteroids address the inflammatory component of asthma. By reducing airway inflammation, edema, and mucus plugging, they shorten the duration of an exacerbation and decrease the risk of relapse after the initial treatment. They are started early in moderate to severe cases, even though their effect is not immediate, because they influence the course of the attack over the next 24 to 72 hours and beyond. Putting these together covers both the immediate bronchospasm and the underlying inflammation, which is why all of these medication classes are effective in managing acute exacerbations of bronchial asthma.

During an acute asthma attack the goal is rapid relief of bronchospasm while also damping the inflammatory process that drives ongoing symptoms. Beta-2 adrenergic receptor agonists provide quick bronchodilation by stimulating smooth muscle relaxation in the airways, which immediately improves airflow, reduces wheeze, and eases shortness of breath.

Anticholinergic drugs add to bronchodilation by blocking acetylcholine’s effect on airway smooth muscle, especially helpful when the attack is moderate to severe or not fully controlled by beta-agonists alone. They help reduce bronchomotor tone and mucus production, providing an extra boost in the acute setting.

Systemic corticosteroids address the inflammatory component of asthma. By reducing airway inflammation, edema, and mucus plugging, they shorten the duration of an exacerbation and decrease the risk of relapse after the initial treatment. They are started early in moderate to severe cases, even though their effect is not immediate, because they influence the course of the attack over the next 24 to 72 hours and beyond.

Putting these together covers both the immediate bronchospasm and the underlying inflammation, which is why all of these medication classes are effective in managing acute exacerbations of bronchial asthma.